After this, 1,049 participants with no diabetes and 983 participants with NGT were follow-up for 4 years, and researchers reported that the low serum OCN level group (<23.33 ng/ml) exhibited an increased risk of T2DM, impaired fasting glucose (IFG), and IR (66). The gene discussed is BGLAP; the disease is type 2 diabetes mellitus.